These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21209412)

  • 21. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier.
    Miura Y; Takenaka T; Toh K; Wu S; Nishihara H; Kano MR; Ino Y; Nomoto T; Matsumoto Y; Koyama H; Cabral H; Nishiyama N; Kataoka K
    ACS Nano; 2013 Oct; 7(10):8583-92. PubMed ID: 24028526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel micelle-encapsulated platinum(II) anticancer agent.
    Jadhav VB; Jun YJ; Song JH; Park MK; Oh JH; Chae SW; Kim IS; Choi SJ; Lee HJ; Sohn YS
    J Control Release; 2010 Oct; 147(1):144-50. PubMed ID: 20654662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.
    Wang Y; Saad M; Pakunlu RI; Khandare JJ; Garbuzenko OB; Vetcher AA; Soldatenkov VA; Pozharov VP; Minko T
    Clin Cancer Res; 2008 Jun; 14(11):3607-16. PubMed ID: 18519795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
    Guo M; Que C; Wang C; Liu X; Yan H; Liu K
    Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxaliplatin: mechanism of action and antineoplastic activity.
    Raymond E; Faivre S; Woynarowski JM; Chaney SG
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):4-12. PubMed ID: 9609103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical antitumor activity of the oral platinum analog satraplatin.
    Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective delivery of oxaliplatin to tumor tissue by nanocarrier system enhances overall therapeutic efficacy of the encapsulated oxaliplatin.
    Lila AS; Kiwada H; Ishida T
    Biol Pharm Bull; 2014; 37(2):206-11. PubMed ID: 24492717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy.
    Pan D; She W; Guo C; Luo K; Yi Q; Gu Z
    Biomaterials; 2014 Dec; 35(38):10080-92. PubMed ID: 25263685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
    Marcucci F; Lefoulon F
    Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of polymeric micelles for the delivery of antitumor agents].
    Nishiyama N; Kataoka K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):357-61. PubMed ID: 19295258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.
    Greish K
    Methods Mol Biol; 2010; 624():25-37. PubMed ID: 20217587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ProLindac (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic.
    Nowotnik DP; Cvitkovic E
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1214-9. PubMed ID: 19671439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in platinum chemotherapeutics.
    Harper BW; Krause-Heuer AM; Grant MP; Manohar M; Garbutcheon-Singh KB; Aldrich-Wright JR
    Chemistry; 2010 Jun; 16(24):7064-77. PubMed ID: 20533453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel bis-platinum complexes endowed with an improved pharmacological profile.
    Gatti L; Perego P; Leone R; Apostoli P; Carenini N; Corna E; Allievi C; Bastrup U; De Munari S; Di Giovine S; Nicoli P; Grugni M; Natangelo M; Pardi G; Pezzoni G; Singer JW; Zunino F
    Mol Pharm; 2010 Feb; 7(1):207-16. PubMed ID: 19919086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-photon-sensitive and sugar-targeted nanocarriers from degradable and dendritic amphiphiles.
    Sun L; Yang Y; Dong CM; Wei Y
    Small; 2011 Feb; 7(3):401-6. PubMed ID: 21294270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination effects of SC144 and cytotoxic anticancer agents.
    Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N
    Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organic nanocarriers for cancer drug delivery.
    López-Dávila V; Seifalian AM; Loizidou M
    Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine.
    Pisano C; Vesci L; Milazzo FM; Guglielmi MB; Foderà R; Barbarino M; D'Incalci M; Zucchetti M; Petrangolini G; Tortoreto M; Perego P; Zuco V; Orlandi A; Passeri D; Carminati P; Cavazza C; Zunino F
    Clin Cancer Res; 2010 Aug; 16(15):3944-53. PubMed ID: 20562210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.